Jubilant Pharmova has reported results for third quarter ended December 31, 2022. (Q3FY23)
The company has reported net loss of Rs 5.89 crore for Q3FY23 as compared to net loss fo Rs 15.60 crore for the corresponding quarter previous year. However, total income of the company increased by 16.21% to Rs 190.61 crore for the quarter under review as compared to Rs 164.02 crore for the same quarter in the previous year.
On the consolidated basis, the company has reported net loss of Rs 16.04 crore for Q3FY23 as compared to net profit of Rs 50.80 crore for the same quarter in the previous year. However, total income of the company increased by 18.65% to Rs 1561.98 crore for the quarter under review as compared to Rs 1316.44 crore for the same quarter in the previous year.
